Overall Survival After Cyclophosphamide, Adriamycin, 5-FU, And Tamoxifen (CAFT) Is Superior To T Alone In Postmenopausal, Receptor (+), Node (+) Breast Cancer: New Findings From Phase III Southwest Oncology Group Intergroup Trial S8814 (INT-0100)

Heather Jones, MD

University of Pennsylvania Cancer
Ultima Vez Modificado: 15 de mayo del 2001

Translation for this article does not exist